Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 1

Conditions

Anemia 8Lymphoma, Large B-Cell, Diffuse 6Lymphoma 4Leukemia 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Prostatic Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Neoplasms, Plasma Cell 3Neoplasms 3Mycosis Fungoides 3Multiple Myeloma 3Monoclonal Gammopathy of Undetermined Significance 3Lymphoproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Prolymphocytic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Large Granular Lymphocytic 3Immunoglobulin Light-chain Amyloidosis 3Immunoblastic Lymphadenopathy 3Hodgkin Disease 3Hematologic Neoplasms 3Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Cyclophosphamide 72fludarabine 65Tacrolimus 43fludarabine phosphate 40Whole-Body Irradiation 37Mycophenolic Acid 35Busulfan 32Melphalan 28Antilymphocyte Serum 23thymoglobulin 22Thiotepa 20Methotrexate 20Standard of Care 19Stem Cell Transplantation 17Practice Guidelines as Topic 17Granulocyte Colony-Stimulating Factor 17Rituximab 15Surveys and Questionnaires 12Sirolimus 12Filgrastim 12Interviews as Topic 11Cyclosporine 11Blood Specimen Collection 11Peripheral Blood Stem Cell Transplantation 10Exercise 10venetoclax 9Mesna 9Cytarabine 9Bortezomib 9Hematopoietic Stem Cell Transplantation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hematologic Neoplasms × Darbepoetin alfa × Clear all
NCT00230321 2013-02-04

A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)

Stanford University

Phase 1/2 Completed
21 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Hematologic Neoplasms

NCT00557817 2010-01-11

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

University of Liege

Phase 2/3 Completed
125 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00355407 2009-03-13

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Completed
31 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡